Back

The impact of late-onset reverse remodeling in heart failure with reduced ejection fraction

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Improving HFrEF therapy further Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hayao Ikesugi

Niigata University Graduate School of Medical and Dental Sciences, Niigata (Japan)

4 More presentations in this session

Presentation thumbnail
Cardiac reverse remodelling of left heart during vericiguat therapy for high-risk HFrEF
Professor A. Lee (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Impact of higher comorbidity burden on guideline-directed medical therapy in patients with heart failure with reduced ejection fraction
Mr J. Krabbe (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Clinical profile and implementation of guideline-directed medical therapy in specialised heart failure clinics: insights from a multicentre registry
Doctor C. Castro (Talca, CL)
Abstract Slides Video
Presentation thumbnail
Interplay between guideline-directed medical therapy and QRS duration in patients with heart failure and reduced ejection fraction: data from the Swedish Heart Failure registry
Doctor R. Laborante (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Improving HFrEF therapy further

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The impact of left ventricular reverse remodeling on asymptomatic structual heart disease
31 August 2025
thumbnail
Congress Presentation
Right ventricular to pulmonary artery coupling: an independent marker in a prediction model for heart failure with improved ejection fraction
28 August 2026
thumbnail
Congress Presentation
Refining arrhythmic risk stratification in hypertrophic cardiomyopathy through left atrial volume and strain
28 August 2026
thumbnail
Congress Presentation
The positive effect of sacubitril/valsartan therapy on QRS width and QTC interval on electrocardiogram in heart failure patients with reduced ejection fraction
9 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources